Extrahepatic cancers and chronic HCV infection

被引:0
作者
Stanislas Pol
Anaïs Vallet-Pichard
Olivier Hermine
机构
[1] Université Paris Descartes,
[2] Unité d'Hépatologie Hôpital Cochin,undefined
[3] Centre de Recherche Translationnelle and INSERM U-1223,undefined
[4] Institut Pasteur,undefined
[5] Paris,undefined
[6] Service d'Hématologie,undefined
[7] Hôpital Necker,undefined
来源
Nature Reviews Gastroenterology & Hepatology | 2018年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Chronic HCV infection is a systemic disease resulting in hepatic and extrahepatic manifestationsGlobally, approximately 15% of human cancers are related to infectious agents such as HCVB cell non-Hodgkin lymphoma (NHL) is associated with HCV infection (relative risk of ∼1.5) and is related to chronic antigenic stimulation and to a lesser extent to direct transformation associated with virus presenceAntiviral therapies enable a sustained virologic and haematological response in two-thirds of patients with HCV-related NHLHCV also infects extrahepatic cells and could induce chronic qualitative and quantitative alterations of the immune repertoire and local tissue microenvironment, which could induce various non-liver cancersChronic HCV infection is generally accepted to increase the risk of NHL and intrahepatic cholangiocarcinoma, and studies of other cancers that take confounding factors into account are warranted
引用
收藏
页码:283 / 290
页数:7
相关论文
共 100 条
  • [1] Schottenfeld D(2015)The cancer burden attributable to biologic agents Ann. Epidemiol. 25 183-187
  • [2] Beebe-Dimmer J(2011)MALT lymphomas: pathogenesis can drive treatment Oncology 25 1134-1142
  • [3] Bertoni F(2006)Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis Oncogene 25 3823-3833
  • [4] Kremsdorf D(2004)Epstein-Barr virus: 40 years on Nat. Rev. Cancer. 4 757-768
  • [5] Soussan P(2010)Human T lymphotropic virus type 1 (HTLV-1): Molecular biology and oncogenesis Viruses 2 2037-2077
  • [6] Paterlini-Brechot P(2014)Human viruses and cancer Viruses 6 4047-4079
  • [7] Brechot P(1999)Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx Oncogene. 18 4848-4859
  • [8] Young LS(1998)Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene J. Virol. 72 3060-3065
  • [9] Rickinson AB(1998)The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat. Med. 4 1065-1067
  • [10] Kannian P(1995)HCV-associated liver cancer without cirrhosis Lancet 345 413-415